BioCentury
ARTICLE | Clinical News

Bavarian Nordic starts HIV Phase I/II

February 15, 2000 8:00 AM UTC

Bavarian Nordic (CSE:BNRI) will start a 10-patient Phase I/II trial in Germany with an MVA F6 vector overproducing HIV- nef protein to treat HIV infection. ...